Butyrylcholinesterase radioligands to image Alzheimer's disease brain

Chemico-Biological Interactions

Volumn 203, Issue 1, 2013, Pages 354-357

  Darvesh, Sultan ^a,b  

^a DALHOUSIE UNIVERSITY   (Canada)

^b MOUNT SAINT VINCENT UNIVERSITY   (Canada)

Author keywords

Alzheimer's; Butyrylcholinesterase; Dementia; Neuroimaging; PET; SPECT

Indexed keywords

AMYLOID BETA PROTEIN; CARBON 11; CHOLINESTERASE; ETHYLENE DICYSTEINE DIETHYL ESTER TC 99M; FLORBETABEN; FLORBETAPIR F 18; FLUORINE 18; FLUORODEOXYGLUCOSE F 18; FLUTEMETAMOL F 18; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; IODINE 123; N METHYL 2 (40 METHYLAMINOPHENYL) 6 HYDROXYBENZOTHIAZOLE C 11; RADIOLIGAND; RADIOPHARMACEUTICAL AGENT; TECHNETIUM 99M; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; AMYLOID PLAQUE; CONFERENCE PAPER; ENZYME ACTIVITY; ENZYME METABOLISM; HUMAN; MOLECULAR IMAGING; NEUROIMAGING; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; RADIOACTIVITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ALZHEIMER DISEASE; ANIMALS; AUTORADIOGRAPHY; BRAIN; BUTYRYLCHOLINESTERASE; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; EARLY DIAGNOSIS; HUMANS; MICE; PLAQUE, AMYLOID; RADIOLIGAND ASSAY;

EID: 84875810405     PISSN: 00092797     EISSN: 18727786     Source Type: Journal    
DOI: 10.1016/j.cbi.2012.08.009     Document Type: Conference Paper

References (26)

1. World Health Organization and Alzheimer's disease International: Dementia: a public health priority (2012).
2. S. Darvesh Diagnosis and management of frontotemporal lobar degeneration J. Geriatr. Care 1 2002 231 236
3. B.T. Hyman, and J.Q. Trojanowski Consensus recommendations for the postmortem diagnosis of Alzheimer disease from the National Institute on Aging and the Reagan Institute Working Group on diagnostic criteria for the neuropathological assessment of Alzheimer disease J. Neuropathol. Exp. Neurol. 56 1997 1095 1097
4. P. Davies, and A.J. Maloney Selective loss of central cholinergic neurons in Alzheimer's disease Lancet 2 1976 1403
5. J.T. Coyle, D.L. Price, and M.R. DeLong Alzheimer's disease: a disorder of cortical cholinergic innervation Science 219 1983 1184 1190
6. E.K. Perry, R.H. Perry, G. Blessed, and B.E. Tomlinson Changes in brain cholinesterases in senile dementia of the Alzheimer type Neuropathol. Appl. Neurobiol. 4 1978 273 277
7. S. Darvesh, G.A. Reid, and E. Martin Biochemical and histochemical comparison of cholinesterases in normal and Alzheimer brain tissues Curr. Alzheimer Res. 7 2010 386 400
8. M.-M. Mesulam, A. Guillozet, P. Shaw, A. Levey, E.G. Duysen, and O. Lockridge Acetylcholinesterase knockouts establish central cholinergic pathways and can use butyrylcholinesterase to hydrolyze acetylcholine Neuroscience 110 2002 627 639
9. S. Darvesh, D.L. Grantham, and D.A. Hopkins Distribution of butyrylcholinesterase in the human amygdala and hippocampal formation J. Comp. Neurol. 393 1998 374 390
10. S. Darvesh, and D.A. Hopkins Differential distribution of butyrylcholinesterase and acetylcholinesterase in the human thalamus J. Comp. Neurol. 463 2003 25 43
11. S. Darvesh, G. Geula, and D.A. Hopkins Neurobiology of butyrylcholinesterase Nat. Rev. Neurosci. 4 2003 131 138
12. M.-M. Mesulam, and C. Geula Chemoarchitectonics of axonal and perikaryal acetylcholinesterase along information processing systems of the human cerebral cortex Brain Res Bull. 33 1994 137 153
13. M.-M. Mesulam, and C. Geula Butyrylcholinesterase reactivity differentiates the amyloid plaques of aging from those of dementia Ann. Neurol. 36 1994 722 727
14. C. Geula, and M.M. Mesulam Cholinesterases and the pathology of Alzheimer disease Alzheimer Dis. Assoc. Disord. 2 1995 23 28
15. D.A. Snowdon, Nun Study, Healthy aging and dementia: findings from the Nun Study. Findings from the Nun Study. Ann. Intern Med. 139 (5 Pt 2) (2003) 450-454.
16. K. Herholz Perfusion SPECT and FDG-PET Int. Psychogeriatr. 23 Suppl 2 2011 S25 S31
17. S. Vallabhajosula Positron emission tomography radiopharmaceuticals for imaging brain beta-amyloid Semin. Nucl. Med. 41 4 2011 283 299
18. C.A. Mathis, Y. Wang, D.P. Holt, G.F. Huang, M.L. Debnath, and W.E. Klunk Synthesis and evaluation of 11C-labeled 6-substituted 2-arylbenzothiazoles as amyloid imaging agents J. Med. Chem. 46 2003 2740 2754
19. S.R. Choi, G. Golding, Z. Zhuang, W. Zhang, N. Lim, F. Hefti, T.E. Benedum, M.R. Kilbourn, D. Skovronsky, and H.F. Kung Preclinical properties of 18F-AV-45: a PET agent for Abeta plaques in the brain J. Nucl. Med. 50 2009 1887 1894
20. K. Herholz, and K. Ebmeier Clinical amyloid imaging in Alzheimer's disease Lancet Neurol. 10 2011 667 770
21. T. Kikuchi, T. Okamura, K. Fukushi, K. Takahashi, J. Toyohara, M. Okada, M.R. Zhang, and T. Irie Cerebral acetylcholinesterase imaging: development of the radioprobes Curr. Top Med. Chem. 7 2007 1790 1799
22. A. Roivainen, J. Rinne, J. Virta, T.J. Arvenpaa, S. Salomaki, M. Yu, and K. Nagren Biodistrubtion and blood metabolism of 1-11C-methyl-4 piperidinyl n-butyrate in humans: an imaging agent for in vivo assessment of butyrylcholinesterase activity with PET J. Nucl. Med. 45 2004 2032 2039
23. T. Kikuchi, M.R. Zhang, N. Ikota, K. Fukushi, T. Okamura, K. Suzuki, Y. Arano, and T. Irie N-[18F]fluoroethylpiperidin-4-ylmethyl butyrate: a novel radiotracer for quantifying brain butyrylcholinesterase activity by positron emission tomography Bioorg. Med. Chem. Lett. 14 2004 1927-1230
24. D.E. Kuhl, R.A. Koeppe, S.E. Snyder, S. Minoshima, K.A. Frey, and M.R. Kilbourn In vivo butyrylcholinesterase activity is not increased in Alzheimer's disease synapses Ann. Neurol. 59 2006 13 20
25. I.R. Macdonald, G.A. Reid, E.E. Joy, I.R. Pottie, G. Matte, S. Burrell, G. Mawko, E. Martin, and S. Darvesh Synthesis and preliminary evaluation of piperidinyl and pyrrolidinyl iodobenzoates as imaging agents for butyrylcholinesterase Mol. Imaging Biol. 13 2011 1250 1261
26. S. Darvesh, M.K. Cash, G.A. Reid, E. Martin, A. Mitnitski, and C. Geula Butyrylcholinesterase is associated with β-amyloid plaques in the transgenic APPSWE/PSEN1dE9 mouse model of Alzheimer disease J. Neuropathol. Exp. Neurol. 1 2012 2 14